Federated Hermes Inc. lessened its stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% in the third quarter, HoldingsChannel.com reports. The firm owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated Hermes Inc.’s holdings in Zentalis Pharmaceuticals were worth $39,071,000 at the end of the […]
Federated Hermes Inc. cut its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was down 4.8% on Friday . The stock traded as low as $14.52 and last traded at $14.70. Approximately 23,268 shares changed hands during trading, a decline of 96% from the average daily volume of 561,417 shares. The stock had previously closed at $15.44. Analyst […]
Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […]